Biogen will charge $56,000-a-year for Alzheimer’s drug
Price over double the highest industry analyst estimate triggers renewed criticism
Price over double the highest industry analyst estimate triggers renewed criticism
Gilead Sciences on how it is bringing its hepatitis C drug Sovaldi to low income countries
Crosswords & puzzles to keep you challenged and entertained
How does a post-Brexit world shape the identity and relationship of these islands
Read the digital edition of The Gloss magazine now
Weddings, Births, Deaths and other family notices